Reference centre of FD/MAS (2022) PNDS : Dysplasie Fibreuse des os et syndrome de McCune-Albright. https://www.has-sante.fr/upload/docs/application/pdf/2022-07/pnds_dysplasie_fibreuse2022_vdef_has.pdf. Accessed Jun 2022
Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT (2019) Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 14(1):139. https://doi.org/10.1186/s13023-019-1102-9
Article PubMed PubMed Central Google Scholar
Karimi M, Brazier J (2016) Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics 34(7):645–649. https://doi.org/10.1007/s40273-016-0389-9
Lenderking WR, Anatchkova M, Pokrzywinski R, Skalicky A, Martin ML, Gelhorn H (2021) Measuring health-related quality of life in patients with rare disease. J Patient Rep Outcomes 5(1):61. https://doi.org/10.1186/s41687-021-00336-8
Article PubMed PubMed Central Google Scholar
Konradi A (2022) Fibrous dysplasia patients with and without craniofacial involvement report reduced quality of life inclusive of stigma, depression, and anxiety. Chronic Illn 4:927–936. https://doi.org/10.1177/17423953211049436
Majoor BCJ, Andela CD, Bruggemann J, van de Sande MAJ, Kaptein AA, Hamdy NAT, Dijkstra PDS, Appelman-Dijkstra NM (2017) Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis 12(1):80. https://doi.org/10.1186/s13023-017-0629-x
Article PubMed PubMed Central Google Scholar
Hagelstein-Rotman M, Genders SW, Andela CD, Dijkstra S, Majoor BCJ, Notting IC, Hamdy NAT, Appelman-Dijkstra NM (2020) Patients With isolated craniofacial dysplasia report better quality of life compared with those with craniofacial dysplasia and extracranial involvement. Ophthalmic Plast Reconstr Surg 36(3):292–297. https://doi.org/10.1097/IOP.0000000000001536
Meier ME, Hagelstein-Rotman M, van de Ven AC, Van der Geest ICM, Donker O, Pichardo SEC, Hissink Muller PCE, van der Meeren SW, Dorleijn DMJ, Winter EM, van de Sande MAJ, Appelman-Dijkstra NM (2022) A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study. Orphanet J Rare Dis 17(1):439. https://doi.org/10.1186/s13023-022-02588-z
Article PubMed PubMed Central Google Scholar
Legrand MA, Bagouet F, Merle B, Gensburger D, Chapurlat R (2023) Value of rare diseases reference centers : impact on diagnosis and access to specialized care in fibrous dysplasia of bone. Eur J Med Genet 66(11):104849. https://doi.org/10.1016/j.ejmg.2023.104849
Article CAS PubMed Google Scholar
Kitzinger J (1995) Qualitative research Introducing focus groups. BMJ (Clinical research ed) 311(7000):299–302. https://doi.org/10.1136/bmj.311.7000.299
Article CAS PubMed Google Scholar
Ware JE et al (1994) SF36 Physical and mental health summary scales: a user’s manual. Health Assessment Lab, New England Medical Center, Boston
Audureau SR, Coste J (2013) Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995–2003. Qual Life Res 22(1):13–26. https://doi.org/10.1007/s11136-012-0117-7
Majoor BCJ, Traunmueller E, Maurer-Ertl W, Appelman-Dijkstra NM, Fink A, Liegl B, Hamdy NAT, Sander Dijkstra PD, Leithner A (2019) Pain in fibrous dysplasia: relationship with anatomical and clinical features. Acta Orthop 90(4):401–405. https://doi.org/10.1080/17453674.2019.1608117
Article PubMed PubMed Central Google Scholar
Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P (2012) Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis. https://doi.org/10.1186/1750-1172-7-S1-S3
Article PubMed PubMed Central Google Scholar
Rotman M, Andela CD, Majoo BCJ, Dijkstra PDS, Hamdy NAT, Kaptein AA, Appelman-Dijkstra NM (2018) Passive coping strategies are associated with more impairment in quality of life in patients with fibrous dysplasia. Calcif Tissue Int 103(5):469–475. https://doi.org/10.1007/s00223-018-0441-1
Article CAS PubMed PubMed Central Google Scholar
Benham-Hutchins M, Staggers N, Mackert M, Johnson AH, deBronkart D (2017) “I want to know everything”: a qualitative study of perspectives from patients with chronic diseases on sharing health information during hospitalization. BMC Health Serv Res 17(1):529. https://doi.org/10.1186/s12913-017-2487-6
Article PubMed PubMed Central Google Scholar
Olsen A, Strand Skjaerven LH, Sundal MA, Magnussen LH (2016) Patient education and basic body awareness therapy in hip osteoarthritis – a qualitative study of patients’ movement learning experiences. Disabil and Rehabil 39(16):1631–1638. https://doi.org/10.1080/09638288.2016.1209578
Lambourne M, Minard LV, Deal H, Pitman J, Rolle M, Saulnier D, Houlihan J (2019) Optimizing patient education of oncology medications: a patient perspective. J Cancer Educ 34(5):1024–1030. https://doi.org/10.1007/s13187-018-1406-9
Article CAS PubMed Google Scholar
Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, Cooper C, Eastell R, Wordsworth P, Javaid MK, Pinedo-Villanueva R (2016) Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis 11(1):160. https://doi.org/10.1186/s13023-016-0538-4
Article PubMed PubMed Central Google Scholar
Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT (2005) Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 37(3):388–394. https://doi.org/10.1016/j.bone.2005.04.026
Ramaswami U, Stull DE, Parini R, Pintos-Morell G, Whybra C, Kalkum G, Rohrbach M, Raluy-Callado M, Beck M, Chen WH, Wiklund I, FOS Investigators (2012) Measuring patient experiences in Fabry disease: validation of the Fabry-specific pediatric health and pain questionnaire (FPHPQ). Health Qual Life Outcomes 10:116. https://doi.org/10.1186/1477-7525-10-116
留言 (0)